Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry

OBJECTIVE: The aim was to evaluate long-term drug retention, discontinuation, efficacy and safety of CT-P13 and reference infliximab in patients with rheumatoid arthritis (RA) enrolled in the Korean College of Rheumatology Biologics (KOBIO) registry. METHODS: Patients included adults with RA who rec...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BioDrugs
Päätekijät: Kim, Hyoun-Ah, Lee, Eunyoung, Lee, Sun-Kyung, Park, Yong-Beom, Lee, Young Nam, Kang, Hee Jung, Shin, Kichul
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2019
Aiheet:
Original Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6985057/
https://ncbi.nlm.nih.gov/pubmed/31734899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-019-00393-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia